Warburg micro syndrome is an autosomal recessive disease where patients present with optic, neurologic and genital symptoms. Until now, four disease genes for Warburg micro syndrome, RAB3GAP1, RAB3GAP2, RAB18 and TBC1D20, have been identified. Here, we report two novel homozygous RAB3GAP1 mutations (c.22G>T, p.Glu8* and c.1353delA, p.Pro452Hisfs*5) in two consanguineous families by whole-exome sequencing.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785564PMC
http://dx.doi.org/10.1038/hgv.2015.34DOI Listing

Publication Analysis

Top Keywords

warburg micro
12
micro syndrome
12
novel homozygous
8
homozygous rab3gap1
8
rab3gap1 mutations
8
mutations warburg
4
syndrome warburg
4
syndrome autosomal
4
autosomal recessive
4
recessive disease
4

Similar Publications

A single-microbe living bioelectronic sensor for intracellular amperometric analysis.

Biosens Bioelectron

December 2024

Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. Electronic address:

Article Synopsis
  • Subcellular amperometric analysis is essential for studying redox chemistry and cell diversity, but challenges arise due to the tiny and complex environment inside cells.
  • This research presents a new living microbial sensor that uses a specific bacteria and a dimidiate microelectrode to measure lactic acid levels electrochemically, providing a reliable electrical signal output.
  • The developed sensor shows a high level of precision, a detection range from 0-60 mM, and effectively discriminates against potential interferences, highlighting its potential in cancer metabolism studies through the Warburg Effect.
View Article and Find Full Text PDF
Article Synopsis
  • Breast cancer poses a significant health risk to women, highlighting the need for more effective treatment options; researchers are exploring the inhibition of glucose metabolism as a potential strategy.
  • The newly identified GAPDH inhibitor, DC-5163, was tested for its ability to hinder breast cancer cell growth both in lab settings and in mouse models, focusing on its effects on cellular energy processes.
  • Results showed that DC-5163 effectively reduced the energy supply of cancer cells, led to cell cycle arrest, increased apoptosis, and significantly suppressed tumor growth in animal models without causing major side effects.
View Article and Find Full Text PDF

Lipid droplets (LDs) comprise a triglyceride core surrounded by a lipid monolayer enriched with proteins, many of which function in LD homeostasis. How proteins are targeted to the growing LD is still unclear. Rab1b, a GTPase regulating secretory transport, was recently associated with targeting proteins to LDs in a Drosophila RNAi screen.

View Article and Find Full Text PDF

Pyruvate Kinase M2, a key enzyme in glycolysis, has garnered significant attention in cancer research due to its pivotal role in the metabolic reprogramming of cancer cells. Originally identified for its association with the Warburg effect, PKM2 has emerged as a multifaceted player in cancer biology. The functioning of PKM2 is intricately regulated at multiple levels, including controlling the gene expression via various transcription factors and non-coding RNAs, as well as adding post-translational modifications that confer distinct functions to the protein.

View Article and Find Full Text PDF

AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers.

Explor Target Antitumor Ther

September 2023

Department of Human Genetics, Faculty of Biomedical Sciences and Technology, Sri Ramachandra Institute of Higher Education and Research (Deemed to be University), Porur, Chennai 600 116, Tamil Nadu, India.

From attributing mutations to cancers with the advent of cutting-edge genetic technology in recent decades, to re-searching the age-old theory of intrinsic metabolic shift of cancers (Warburg's glycolysis), the quest for a precise panacea for mainly the metastatic cancers, remains incessant. This review delineates the advanced glycation end product (AGE)-receptor for AGE (RAGE) pathway driven intricate oncogenic cues, budding from the metabolic (glycolytic) reliance of tumour cells, branching into metastatic emergence of malignancies. Strong AGE-RAGE concomitance in metastasis, chemo-resistance and cancer resurgence adversely incite disease progression and patient mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!